SCHEMBL14885669

SCHEMBL14885669

CCc1noc(C)c1C(=O)Nc1ccc(-c2cc3c(cc2C)OC(F)(F)O3)cn1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 2/20 0.50
▸ ORAI1 Q96D31 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ RAB9A P51151 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ ORAI2 Q96SN7 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ GPR55 Q9Y2T6 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16020574 0.92 STIM1 (0.49) STIM1ORAI1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14885666 0.91 STIM1 (0.50) STIM1ORAI1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL16019818 0.89 CYP1A2 (0.46) SMN1; SMN2ALDH1A1RAB9ANPC1CYP1A2
SCHEMBL16020542 0.87 STIM1 (0.54) STIM1ORAI1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14885667 0.85 STIM1 (0.48) STIM1ORAI1ALDH1A1CYP2C9CYP2C19
SCHEMBL16018215 0.84 STIM1 (0.51) STIM1ORAI1ALDH1A1CYP2C9CYP2C19
SCHEMBL16020571 0.81 STIM1 (0.48) STIM1ORAI1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL16018175 0.81 STIM1 (0.52) STIM1ORAI1ALDH1A1RAB9ANPC1
SCHEMBL16018193 0.81 STIM1 (0.50) STIM1ORAI1ALDH1A1RAB9ANPC1
SCHEMBL16020558 0.81 STIM1 (0.50) STIM1ORAI1ORAI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256745-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2014-09-11 — — US disclosed
WO-2013059677-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256745-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885SMN1; SMN2 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback